These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2388037)

  • 1. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
    Chen BP; Madrigal A; Parham P
    J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
    Freer G; Senesi S
    Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
    Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
    Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
    Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
    Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways.
    Demotz S; Péléraux A
    Mol Immunol; 1996; 33(4-5):387-97. PubMed ID: 8676890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.
    Tsang KY; Zaremba S; Nieroda CA; Zhu MZ; Hamilton JM; Schlom J
    J Natl Cancer Inst; 1995 Jul; 87(13):982-90. PubMed ID: 7629885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Cox JH; Yewdell JW; Eisenlohr LC; Johnson PR; Bennink JR
    Science; 1990 Feb; 247(4943):715-8. PubMed ID: 2137259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class I and II molecules present influenza virus antigens with different kinetics.
    Kuijpers KC; van Kemenade FJ; Hooibrink B; Neefjes JJ; Lucas CJ; van Lier RA; Miedema F
    Eur J Immunol; 1992 Sep; 22(9):2339-45. PubMed ID: 1516624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope.
    Deng J; Lu C; Liu C; Oveissi S; Fairlie WD; Lee EF; Bilsel P; Puthalakath H; Chen W
    FEBS J; 2021 May; 288(10):3164-3185. PubMed ID: 33830641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.
    Malnati MS; Marti M; LaVaute T; Jaraquemada D; Biddison W; DeMars R; Long EO
    Nature; 1992 Jun; 357(6380):702-4. PubMed ID: 1614517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.